US0905722072 - Common Stock
BIO-RAD LABORATORIES-A
NYSE:BIO (10/11/2024, 8:04:00 PM)
After market: 336.92 0 (0%)336.92
+3.52 (+1.06%)
Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. The company is headquartered in Hercules, California and currently employs 8,030 full-time employees. The firm offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. The firm operates through two segments: Life Science and Clinical Diagnostics. Its Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes and food testing regimes. The Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are primarily sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.
BIO-RAD LABORATORIES-A
1000 Alfred Nobel Dr
Hercules CALIFORNIA 94547
P: 15107247000
CEO: Norman Schwartz
Employees: 8030
Website: https://www.bio-rad.com/
History says Palantir stock could soar after its inclusion in the S&P 500.
/PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior...
Palantir, Dell Technologies and Erie Indemnity will join the S&P 500 on Sept. 23. All three stocks jumped late Friday.
Here you can normally see the latest stock twits on BIO, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: